NASD
| Health Care |
Biotechnology
4D Molecular Therapeutics Inc. (FDMT)
LAST (3 Apr)
After-Hours (18:39:08 ET)
MARKET CAP
VOLUME
| Open | 3.12 |
| Previous Close | 3.28 |
| Day Range | 2.88 - 3.12 |
| 52-Week Range | 2.87 - 29.26 |
| All-Time High | 55.11 |
| Avg. Volume (50-day) | 840,711.44 |
| EPS (TTM) | -3.16 |
| Next Earnings Date | 2025-05-08 (AMC) |
| Last Earnings Date | 2025-02-28 |
| Forward Annual Dividend (Yield) | - |
| Trailing Annual Dividend (Yield) | - |
| Options | Yes |
| P/E Ratio | -1.04 |
| PEG Ratio | - |
| Price to Book | 0.29 |
| Price to Cash Flow | - |
| Price to Free Cash Flow | - |
| Total Sales (TTM) | 0.04 M |
| Revenue per Share (TTM) | 0.00 |
| Shares Outstanding | 46.302 M |
| Share Float (%) | 39.63 M |
| % Held by Institutions | 91.98 |
| Dividends Per Share (TTM) | - |
| Ex-Dividend Date | - |
| +/- EMA(20) | 3.69 (-21.82%) |
| +/- SMA(50) | 4.46 (-35.31%) |
| +/- SMA(200) | 10.28 (-71.94%) |
| 5-Day Perf. | -18.96% |
| 1-Month Perf. | -30.31% |
| 3-Month Perf. | -51.35% |
| 6-Month Perf. | -72.1% |
| YTD Perf. | -48.2% |
| 1-Year Perf. | -89.67% |
| RSI(14) | 29.94 |
| ATR(14) | 0.34 |
| ADX(14) | 23.62 |
| Beta (5Y) | 1.27 |
FOR STOCKCHARTS MEMBERS ONLY
Unlock earnings and revenue history when you join StockCharts
As a StockCharts Member, you can review earnings results and analyze revenue and earnings growth over time. Bring a balance of technicals and fundamentals to your approach when you join today!
FDMT
4D Molecular Therapeutics Inc.
Sector: Health Care
Industry: Biotechnology
Employees: 227
Description
4DMT operates as a clinical-stage genetic medicines company focused on inventing and developing genetic medicines to treat large market diseases in ophthalmology, pulmonology and cardiology. It develops genetic medicines using its proprietary invention platform, Therapeutic Vector Evolution. It combines the power of the Nobel Prize-winning technology, directed evolution, with approximately one billion synthetic AAV capsid-derived sequences. Its product design, development and manufacturing engine create a valuable and diverse product pipeline. The company is currently advancing five clinical-stage and two preclinical product candidates, each tailored to address rare and large market diseases. 4DMT was founded by David H. Kirn, Melissa Kotterman, Theresa Janke, and David Schaffer on September 12, 2013 and is headquartered in Emeryville, CA.
FDMT has triggered the following predefined scans:
| P&F Double Bottom Breakdown |
| P&F Descending Triple Bottom Breakdown |
| Moved Below Lower Bollinger Band |
| Elder Bar Turned Red |
| Moved Below Lower Keltner Channel |
FOR STOCKCHARTS MEMBERS ONLY
Unlock custom technical alerts when you join StockCharts
As a StockCharts Member, you can create your own unique alerts with the technical criteria that matters most to you. Stay ahead of important moves and never miss a thing in the markets.
FOR STOCKCHARTS MEMBERS ONLY
Unlock ChartLists to save and organize your charts when you join StockCharts
As a StockCharts Member, you can save the charts you're watching to your own account with ChartLists. Accessible from any device, you can organize, review and analyze your charts on-the-go, anytime, anywhere.
